Response to Comments on “Aberrant type 1 immunity drives susceptibility to mucosal fungal infections”

Timothy J. Break, Vasileios Oikonomou, Nicolas Dutzan, Jigar V. Desai, Marc Swidergall, Tilo Freiwald, Daniel Chauss, Oliver J. Harrison, Julie Alejo, Drake W. Williams, Stefania Pittaluga, Chyi-Chia R. Lee, Nicolas Bouladoux, Muthulekha Swamydas, Kevin W. Hoffman, Teresa Greenwell-Wild, Vincent M. Bruno, Lindsey B. Rosen, Wint Lwin, Andy RenteriaSergio M. Pontejo, John P. Shannon, Ian A. Myles, Peter Olbrich, Elise M. N. Ferré, Monica Schmitt, Daniel Martin, Genomics and Computational Biology Core16, Daniel L. Barber, Norma V. Solis, Luigi D. Notarangelo, David V. Serreze, Mitsuru Matsumoto, Heather D. Hickman, Philip M. Murphy, Mark S. Anderson, Jean K. Lim, Steven M. Holland, Scott G. Filler, Behdad Afzali, Yasmine Belkaid, Niki M. Moutsopoulos, Michail S. Lionakis

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish (US)
JournalScience
DOIs
StatePublished - Sep 16 2021

Cite this